CXCL8 and COVID-19: IL-8, a chemokine released early after infection, plays a key role in the recruitment and activation of neutrophils during inflammatory responses (Baggiolini et al., 1989); and due to the neutrophilia observed in COVID-19 patients, IL-8 may sustain its pathogenesis (Del Valle et al., 2020).